Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-01-18
2011-01-18
Padmanabhan, Sreeni (Department: 1627)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S277000, C514S279000, C514S338000, C514S411000
Reexamination Certificate
active
07872023
ABSTRACT:
Kappa opioid receptor antagonists are provided that yield significant improvements in functional binding assays to kappa opioid receptors, and the use of these antagonists in treatment of disease states that are ameliorated by binding of the kappa opioid receptor such as heroin or cocaine addictions.
REFERENCES:
patent: 4891379 (1990-01-01), Zimmerman et al.
patent: 5128118 (1992-07-01), Carroll et al.
patent: 5141959 (1992-08-01), Carroll et al.
patent: 5298499 (1994-03-01), Carroll et al.
patent: 5380848 (1995-01-01), Kuhar et al.
patent: 5413779 (1995-05-01), Kuhar et al.
patent: 5457208 (1995-10-01), Portoghese et al.
patent: 5496953 (1996-03-01), Kuhar et al.
patent: 5736123 (1998-04-01), Carroll
patent: 5831095 (1998-11-01), Gonzalez et al.
patent: 5935953 (1999-08-01), Kuhar et al.
patent: 6123917 (2000-09-01), Carroll
patent: 6329520 (2001-12-01), Carroll et al.
patent: 6358492 (2002-03-01), Kuhar et al.
patent: 6416735 (2002-07-01), Carroll et al.
patent: 6479509 (2002-11-01), Carroll
patent: 6531481 (2003-03-01), Carroll et al.
patent: 6531483 (2003-03-01), Kuhar et al.
patent: 6538010 (2003-03-01), Carroll
patent: 6552032 (2003-04-01), Carroll et al.
patent: 6559159 (2003-05-01), Carroll et al.
patent: 6593348 (2003-07-01), Carroll et al.
patent: 6706880 (2004-03-01), Carroll et al.
patent: 2002/0132828 (2002-09-01), Carroll et al.
patent: 2002/0188003 (2002-12-01), Kuhar et al.
patent: 2003/0158415 (2003-08-01), Carroll et al.
patent: 2003/0176434 (2003-09-01), Carroll
patent: 2003/0203934 (2003-10-01), Kuhar et al.
patent: 2004/0146518 (2004-07-01), Carroll et al.
patent: WO 02/053533 (2002-07-01), None
patent: WO 2004/082623 (2004-09-01), None
Carroll, “Pharmacological properties of JDTic: a novel n-opioid receptor antagonist”, European Journal of Pharmacology, 2004, 501, pp. 111-119.
U.S. Appl. No. 11/272,492, filed Nov. 14, 2005, Carroll.
U.S. Appl. No. 12/105,814, filed Apr. 18, 2008, Carroll, et al.
U.S. Appl. No. 09/623,872, filed Oct. 17, 2000, Carroll et al.
U.S. Appl. No. 11/189,068, filed Jul. 26, 2005, Carroll et al.
U.S. Appl. No. 11/113,158, filed Apr. 25, 2005, Carroll et al.
U.S. Appl. No. 10/986,352, filed Nov. 12, 2004, Kuhar et al.
U.S. Appl. No. 10/259,780, filed Sep. 30, 2002, Carroll et al.
U.S. Appl. No. 09/537,668, filed Mar. 29, 2000, Carroll et al.
U.S. Appl. No. 60/107,902, filed Nov. 10, 1998, Carroll.
U.S. Appl. No. 08/701,503, filed Aug. 22, 1996, Boja et al.
U.S. Appl. No. 08/506,541, filed Jul. 24, 1995, Kuhar et al.
U.S. Appl. No. 11/863,587, filed Sep. 28, 2007, Kuhar et al.
U.S. Appl. No. 12/551,072, filed Aug. 31, 2009, Carroll.
Australian Office Action issued Sep. 20, 2010, in Application Serial No. 2006214118.
Brieaddy Lawrence E.
Carroll Frank Ivy
Navarro Hernan A.
Runyon Scott P.
Thomas James B.
Javanmard Sahar
Oblon, Spivak McClelland, Maier & Neustadt, L.L.P.
Padmanabhan Sreeni
Research Triangle Institute
LandOfFree
Kappa opioid receptor ligands does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Kappa opioid receptor ligands, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Kappa opioid receptor ligands will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2730033